Clinical trial
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed…
NCT00082797 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00082797 |
|---|---|
| Title | High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase II Study Of Systemic High-Dose Methotrexate For The Treatment Of Glioblastoma Multiforme In Newly Diagnosed Patients With Measurable Disease |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | leucovorin calcium, methotrexate |
| Enrollment | 36 |
| Start date | Jul 12, 2005 |
| Primary completion | May 1, 2007 |
| First posted | May 19, 2004 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: